Benefit-risk balance for marketed drugs: evaluating safety signals
Sábháilte in:
| Údar corparáideach: | |
|---|---|
| Formáid: | LEABHAR |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Geneva
Council for International Organizations of Medical Sciences (CIOMS)
1998
|
| Ábhair: | |
| Rochtain ar líne: | Visit NHRC Library |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
| LEADER | 00880nam a22002177a 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20220906184638.0 | ||
| 008 | 140831b xxu||||| |||| 00| 0 eng d | ||
| 020 | |a 9290360682 | ||
| 110 | |a Council for International Organizations of Medical Sciences (CIOMS) |9 2393 | ||
| 245 | |a Benefit-risk balance for marketed drugs: evaluating safety signals | ||
| 260 | |a Geneva |b Council for International Organizations of Medical Sciences (CIOMS) |c 1998 | ||
| 300 | |a 160p. | ||
| 650 | |a Drugs |9 333 | ||
| 650 | |a Pharmaceutic Preparations |9 2394 | ||
| 650 | |a Pharmaceutical Products |9 2395 | ||
| 650 | |a Preparations, Pharmaceutical |9 2396 | ||
| 856 | |u http://nhrc.org.np/contact |y Visit NHRC Library | ||
| 942 | |2 NLM |c BK | ||
| 952 | |0 0 |1 0 |2 NLM |4 0 |6 QV_55_000000000000000_CIO_1998 |7 0 |9 2039 |a NHRC |b NHRC |d 2014-08-31 |l 0 |o QV 55/CIO/1998 |p 000387 |r 2014-08-31 |w 2014-08-31 |y BK | ||
| 999 | |c 1977 |d 1977 | ||